OBJECTIVES: To identify physical activity that is beneficial for the maintenance of bone strength with increasing age by examining the relation between bone mineral density (BMD) and chronic endurance training in men. BMD at the proximal femur, its subregions, and the lumbar spine, and serum testosterone were compared between two groups of long distance runners with more than 20 years of training experience and non-athletic controls. METHODS: Runners (n = 12) were divided into (a) high volume runners (n = 7), running 64-80 km a week, and (b) very high volume runners (n = 5), running more than 95 km a week, and compared with non-athletic male controls, exercising in non-endurance oriented activities two to four times a week. BMD (g/cm2) at the total proximal femur, femoral neck, trochanteric region, and lumbar spine was measured by dual energy x ray absorptiometry. Total testosterone (nmol/l) and free testosterone (pmol/l) in serum were measured by radioimmunoassay from single fasting blood samples. RESULTS: Height, weight, and age (range = 40-55 years) were not significantly different between groups. The high volume runners had significantly higher BMD at the total proximal femur (1.09 (0.17) v 0.94 (0.056)), femoral neck (0.91 (0.16) v 0.78 (0.071)), and trochanteric region (0.85 (0.14) v 0.73 (0.053)) than controls (p<0.05). The differences in BMD for the proximal femur between the very high volume runners and the other two groups were not significant. There was no difference in lumbar spine BMD, total testosterone, or free testosterone between groups. However, there was a significant negative correlation between total testosterone (r = -0.73, p<0.01) and free testosterone (r = -0.79, p<0.005) and running volume in the distance runners. CONCLUSIONS: Long term distance running with training volumes less than 80 km a week had a positive effect on BMD of the proximal femur. With running volumes greater than 64 km a week, training was inversely related to testosterone levels, but levels remained within the normal range.
OBJECTIVES: To identify physical activity that is beneficial for the maintenance of bone strength with increasing age by examining the relation between bone mineral density (BMD) and chronic endurance training in men. BMD at the proximal femur, its subregions, and the lumbar spine, and serum testosterone were compared between two groups of long distance runners with more than 20 years of training experience and non-athletic controls. METHODS: Runners (n = 12) were divided into (a) high volume runners (n = 7), running 64-80 km a week, and (b) very high volume runners (n = 5), running more than 95 km a week, and compared with non-athletic male controls, exercising in non-endurance oriented activities two to four times a week. BMD (g/cm2) at the total proximal femur, femoral neck, trochanteric region, and lumbar spine was measured by dual energy x ray absorptiometry. Total testosterone (nmol/l) and free testosterone (pmol/l) in serum were measured by radioimmunoassay from single fasting blood samples. RESULTS: Height, weight, and age (range = 40-55 years) were not significantly different between groups. The high volume runners had significantly higher BMD at the total proximal femur (1.09 (0.17) v 0.94 (0.056)), femoral neck (0.91 (0.16) v 0.78 (0.071)), and trochanteric region (0.85 (0.14) v 0.73 (0.053)) than controls (p<0.05). The differences in BMD for the proximal femur between the very high volume runners and the other two groups were not significant. There was no difference in lumbar spine BMD, total testosterone, or free testosterone between groups. However, there was a significant negative correlation between total testosterone (r = -0.73, p<0.01) and free testosterone (r = -0.79, p<0.005) and running volume in the distance runners. CONCLUSIONS: Long term distance running with training volumes less than 80 km a week had a positive effect on BMD of the proximal femur. With running volumes greater than 64 km a week, training was inversely related to testosterone levels, but levels remained within the normal range.
Authors: P Kannus; H Haapasalo; M Sankelo; H Sievänen; M Pasanen; A Heinonen; P Oja; I Vuori Journal: Ann Intern Med Date: 1995-07-01 Impact factor: 25.391
Authors: B P Conroy; W J Kraemer; C M Maresh; S J Fleck; M H Stone; A C Fry; P D Miller; G P Dalsky Journal: Med Sci Sports Exerc Date: 1993-10 Impact factor: 5.411
Authors: James M Dominguez; Robert T Davis; Danielle J McCullough; John N Stabley; Bradley J Behnke Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-06-15 Impact factor: 3.619
Authors: Kathryn E Ackerman; Gary S Skrinar; Eva Medvedova; Madhusmita Misra; Karen K Miller Journal: Clin Endocrinol (Oxf) Date: 2012-03 Impact factor: 3.478
Authors: Diana Ruiz-Vicente; Teresa García-Pastor; Beatriz Lara; Juan José Salinero; Francisco Areces; César Gallo-Salazar; Javier Abián-Vicén; Fernando Jiménez; Juan Del Coso Journal: Arch Osteoporos Date: 2021-06-02 Impact factor: 2.617